Logo image of HBI

HANESBRANDS INC (HBI) Stock Fundamental Analysis

NYSE:HBI - New York Stock Exchange, Inc. - US4103451021 - Common Stock - Currency: USD

4.89  -0.15 (-2.98%)

After market: 4.91 +0.02 (+0.41%)

Fundamental Rating

3

Taking everything into account, HBI scores 3 out of 10 in our fundamental rating. HBI was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. HBI may be in some trouble as it scores bad on both profitability and health. HBI is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

HBI had positive earnings in the past year.
In the past year HBI had a positive cash flow from operations.
In the past 5 years HBI reported 4 times negative net income.
Of the past 5 years HBI 4 years had a positive operating cash flow.
HBI Yearly Net Income VS EBIT VS OCF VS FCFHBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of -8.34%, HBI is doing worse than 75.00% of the companies in the same industry.
HBI's Return On Equity of -942.17% is on the low side compared to the rest of the industry. HBI is outperformed by 89.58% of its industry peers.
HBI's Return On Invested Capital of 12.65% is fine compared to the rest of the industry. HBI outperforms 70.83% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HBI is below the industry average of 13.45%.
The last Return On Invested Capital (12.65%) for HBI is above the 3 year average (9.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -8.34%
ROE -942.17%
ROIC 12.65%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
HBI Yearly ROA, ROE, ROICHBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

HBI's Operating Margin of 11.84% is amongst the best of the industry. HBI outperforms 81.25% of its industry peers.
HBI's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 41.36%, HBI is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
HBI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.84%
PM (TTM) N/A
GM 41.36%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
HBI Yearly Profit, Operating, Gross MarginsHBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1

2. Health

2.1 Basic Checks

HBI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, HBI has more shares outstanding
HBI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for HBI is higher compared to a year ago.
HBI Yearly Shares OutstandingHBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
HBI Yearly Total Debt VS Total AssetsHBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that HBI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.77, HBI is doing worse than 75.00% of the companies in the same industry.
HBI has a debt to FCF ratio of 10.08. This is a negative value and a sign of low solvency as HBI would need 10.08 years to pay back of all of its debts.
The Debt to FCF ratio of HBI (10.08) is worse than 60.42% of its industry peers.
HBI has a Debt/Equity ratio of 64.28. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 64.28, HBI is not doing good in the industry: 93.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 64.28
Debt/FCF 10.08
Altman-Z 1.77
ROIC/WACC1.22
WACC10.35%
HBI Yearly LT Debt VS Equity VS FCFHBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

HBI has a Current Ratio of 1.37. This is a normal value and indicates that HBI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.37, HBI is doing worse than 79.17% of the companies in the same industry.
HBI has a Quick Ratio of 1.37. This is a bad value and indicates that HBI is not financially healthy enough and could expect problems in meeting its short term obligations.
HBI has a worse Quick ratio (0.68) than 85.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.68
HBI Yearly Current Assets VS Current LiabilitesHBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 440.00% over the past year.
HBI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.96% yearly.
The Revenue has decreased by -3.63% in the past year.
HBI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.40% yearly.
EPS 1Y (TTM)440%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%450%
Revenue 1Y (TTM)-3.63%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-34.25%

3.2 Future

The Earnings Per Share is expected to grow by 14.06% on average over the next years. This is quite good.
The Revenue is expected to grow by 0.94% on average over the next years.
EPS Next Y21.72%
EPS Next 2Y15.11%
EPS Next 3Y17.2%
EPS Next 5Y14.06%
Revenue Next Year-3.24%
Revenue Next 2Y-1.87%
Revenue Next 3Y-0.21%
Revenue Next 5Y0.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HBI Yearly Revenue VS EstimatesHBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
HBI Yearly EPS VS EstimatesHBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.06, the valuation of HBI can be described as very reasonable.
81.25% of the companies in the same industry are more expensive than HBI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.82, HBI is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.20, the valuation of HBI can be described as reasonable.
87.50% of the companies in the same industry are more expensive than HBI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of HBI to the average of the S&P500 Index (21.76), we can say HBI is valued rather cheaply.
Industry RankSector Rank
PE 9.06
Fwd PE 8.2
HBI Price Earnings VS Forward Price EarningsHBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HBI indicates a somewhat cheap valuation: HBI is cheaper than 72.92% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, HBI is valued a bit cheaper than the industry average as 79.17% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.64
EV/EBITDA 7.48
HBI Per share dataHBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5

4.3 Compensation for Growth

HBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HBI's earnings are expected to grow with 17.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3Y17.2%

0

5. Dividend

5.1 Amount

No dividends for HBI!.
Industry RankSector Rank
Dividend Yield N/A

HANESBRANDS INC

NYSE:HBI (5/23/2025, 8:21:00 PM)

After market: 4.91 +0.02 (+0.41%)

4.89

-0.15 (-2.98%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners98.03%
Inst Owner Change-4.87%
Ins Owners0.8%
Ins Owner Change4.67%
Market Cap1.73B
Analysts50.77
Price Target5 (2.25%)
Short Float %8.59%
Short Ratio3.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.88%
Min EPS beat(2)17.38%
Max EPS beat(2)24.38%
EPS beat(4)4
Avg EPS beat(4)41.98%
Min EPS beat(4)17.38%
Max EPS beat(4)70.66%
EPS beat(8)6
Avg EPS beat(8)19.96%
EPS beat(12)8
Avg EPS beat(12)14.15%
EPS beat(16)11
Avg EPS beat(16)15.54%
Revenue beat(2)0
Avg Revenue beat(2)-8%
Min Revenue beat(2)-8.58%
Max Revenue beat(2)-7.43%
Revenue beat(4)0
Avg Revenue beat(4)-11.69%
Min Revenue beat(4)-27.34%
Max Revenue beat(4)-3.41%
Revenue beat(8)1
Avg Revenue beat(8)-7.11%
Revenue beat(12)2
Avg Revenue beat(12)-5.82%
Revenue beat(16)3
Avg Revenue beat(16)-3.99%
PT rev (1m)-22.63%
PT rev (3m)-22.63%
EPS NQ rev (1m)-3.54%
EPS NQ rev (3m)-23.05%
EPS NY rev (1m)4.33%
EPS NY rev (3m)-0.46%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-4.2%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.82%
Valuation
Industry RankSector Rank
PE 9.06
Fwd PE 8.2
P/S 0.49
P/FCF 7.64
P/OCF 6.54
P/B 50.85
P/tB N/A
EV/EBITDA 7.48
EPS(TTM)0.54
EY11.04%
EPS(NY)0.6
Fwd EY12.19%
FCF(TTM)0.64
FCFY13.09%
OCF(TTM)0.75
OCFY15.28%
SpS9.92
BVpS0.1
TBVpS-4.22
PEG (NY)0.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.34%
ROE -942.17%
ROCE 16.01%
ROIC 12.65%
ROICexc 13.8%
ROICexgc 38.45%
OM 11.84%
PM (TTM) N/A
GM 41.36%
FCFM 6.45%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
ROICexc(3y)9.89%
ROICexc(5y)12.07%
ROICexgc(3y)24.54%
ROICexgc(5y)28.18%
ROCE(3y)11.7%
ROCE(5y)13.75%
ROICexcg growth 3Y-1.22%
ROICexcg growth 5Y5.88%
ROICexc growth 3Y-7.77%
ROICexc growth 5Y0.09%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
F-Score4
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 64.28
Debt/FCF 10.08
Debt/EBITDA 4.31
Cap/Depr 41.16%
Cap/Sales 1.08%
Interest Coverage 1.73
Cash Conversion 52.1%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.68
Altman-Z 1.77
F-Score4
WACC10.35%
ROIC/WACC1.22
Cap/Depr(3y)95.15%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.91%
Cap/Sales(5y)1.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)440%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%450%
EPS Next Y21.72%
EPS Next 2Y15.11%
EPS Next 3Y17.2%
EPS Next 5Y14.06%
Revenue 1Y (TTM)-3.63%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-34.25%
Revenue Next Year-3.24%
Revenue Next 2Y-1.87%
Revenue Next 3Y-0.21%
Revenue Next 5Y0.94%
EBIT growth 1Y2.58%
EBIT growth 3Y-23.76%
EBIT growth 5Y-14.59%
EBIT Next Year26.54%
EBIT Next 3Y9.56%
EBIT Next 5Y8.59%
FCF growth 1Y-56.28%
FCF growth 3Y-25.8%
FCF growth 5Y-20.26%
OCF growth 1Y-52.96%
OCF growth 3Y-24.88%
OCF growth 5Y-19.94%